Table 2 Current Treatment Regimens
Treatment regimen | Boceprevir-experienced | Telaprevir-experienced |
|---|---|---|
LDV/SOF, n (%) | n = 63 | n = 105 |
LDV/SOF 12 weeks | 11 (8.7%) | 26 (12.5%) |
LDV/SOF 24 weeks | 6 (4.7%) | 9 (4.3%) |
LDV/SOF + RBV 12 weeks | 41 (32.3%) | 63 (30.3%) |
LDV/SOF + RBV 24 weeks | 5 (3.9%) | 7 (3.4%) |
PrOD, n (%) | n = 64 | n = 103 |
PrOD 12 weeks | 29 (22.8%) | 42 (20.2%) |
PrOD+RBV 12 weeks | 33 (26%) | 56 (26.9%) |
PrOD+RBV 24 weeks | 2 (1.6%) | 5 (2.4%) |